Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bergemalm

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitisSailish Honap, Joelle St-Pierre, Michael Colwill, et al.
Journal of Crohn'S & Colitis|April 19, 2025
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotypeEleftheria Pertsinidou, Benita Salomon, Daniel Bergemalm, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitisSailish Honap, Joelle St-Pierre, Michael Colwill, et al.
Journal of Crohn'S & Colitis|April 19, 2025
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotypeEleftheria Pertsinidou, Benita Salomon, Daniel Bergemalm, et al.
European Journal of Gastroenterology & Hepatology|August 23, 2018
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD studyStefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, et al.
United European Gastroenterology Journal|July 28, 2020
The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD studyJohan Burisch, Daniel Bergemalm, Jonas Halfvarson, et al.
Pageof 5